128 related articles for article (PubMed ID: 15252797)
1. The immunogenicity of the tumor-associated antigen Lewis(y) may be suppressed by a bifunctional cross-linker required for coupling to a carrier protein.
Buskas T; Li Y; Boons GJ
Chemistry; 2004 Jul; 10(14):3517-24. PubMed ID: 15252797
[TBL] [Abstract][Full Text] [Related]
2. Constructing an adenocarcinoma vaccine: immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies.
Ragupathi G; Deshpande PP; Coltart DM; Kim HM; Williams LJ; Danishefsky SJ; Livingston PO
Int J Cancer; 2002 May; 99(2):207-12. PubMed ID: 11979435
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of a dimeric Lewis antigen and the evaluation of the epitope specificity of antibodies elicited in mice.
Buskas T; Li Y; Boons GJ
Chemistry; 2005 Sep; 11(18):5457-67. PubMed ID: 16013028
[TBL] [Abstract][Full Text] [Related]
4. Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells.
Ragupathi G; Howard L; Cappello S; Koganty RR; Qiu D; Longenecker BM; Reddish MA; Lloyd KO; Livingston PO
Cancer Immunol Immunother; 1999 Apr; 48(1):1-8. PubMed ID: 10235483
[TBL] [Abstract][Full Text] [Related]
5. Structural convergence of antibody binding of carbohydrate determinants in Lewis Y tumor antigens.
Ramsland PA; Farrugia W; Bradford TM; Mark Hogarth P; Scott AM
J Mol Biol; 2004 Jul; 340(4):809-18. PubMed ID: 15223322
[TBL] [Abstract][Full Text] [Related]
6. Potent antigen-specific immune response induced by infusion of spleen cells coupled with succinimidyl-4-(N-maleimidomethyl cyclohexane)-1-carboxylate (SMCC) conjugated antigens.
Guo Y; Werbel T; Wan S; Wu H; Li Y; Clare-Salzler M; Xia CQ
Int Immunopharmacol; 2016 Feb; 31():158-68. PubMed ID: 26735611
[TBL] [Abstract][Full Text] [Related]
7. Function-spacer-lipid constructs of Lewis and chimeric Lewis/ABH glycans. Synthesis and use in serological studies.
Ryzhov IM; Korchagina EY; Tuzikov AB; Popova IS; Tyrtysh TV; Pazynina GV; Henry SM; Bovin NV
Carbohydr Res; 2016 Nov; 435():83-96. PubMed ID: 27721143
[TBL] [Abstract][Full Text] [Related]
8. Comparative immunological studies of tumor-associated Lewis X, Lewis Y, and KH-1 antigens.
Guo J; Jiang W; Li Q; Jaiswal M; Guo Z
Carbohydr Res; 2020 Jun; 492():107999. PubMed ID: 32272238
[TBL] [Abstract][Full Text] [Related]
9. Immunization of ovarian cancer patients with a synthetic Lewis(y)-protein conjugate vaccine: a phase 1 trial.
Sabbatini PJ; Kudryashov V; Ragupathi G; Danishefsky SJ; Livingston PO; Bornmann W; Spassova M; Zatorski A; Spriggs D; Aghajanian C; Soignet S; Peyton M; O'Flaherty C; Curtin J; Lloyd KO
Int J Cancer; 2000 Jul; 87(1):79-85. PubMed ID: 10861456
[TBL] [Abstract][Full Text] [Related]
10. Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis(y) conjugates in mice.
Kudryashov V; Glunz PW; Williams LJ; Hintermann S; Danishefsky SJ; Lloyd KO
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3264-9. PubMed ID: 11248067
[TBL] [Abstract][Full Text] [Related]
11. Antibody-targeted chemotherapy with the calicheamicin conjugate hu3S193-N-acetyl gamma calicheamicin dimethyl hydrazide targets Lewisy and eliminates Lewisy-positive human carcinoma cells and xenografts.
Boghaert ER; Sridharan L; Armellino DC; Khandke KM; DiJoseph JF; Kunz A; Dougher MM; Jiang F; Kalyandrug LB; Hamann PR; Frost P; Damle NK
Clin Cancer Res; 2004 Jul; 10(13):4538-49. PubMed ID: 15240546
[TBL] [Abstract][Full Text] [Related]
12. A single-step method for the production of sugar hydrazides: intermediates for the chemoselective preparation of glycoconjugates.
Flinn NS; Quibell M; Monk TP; Ramjee MK; Urch CJ
Bioconjug Chem; 2005; 16(3):722-8. PubMed ID: 15898743
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of selected LeY and KH-1 analogues: a medicinal chemistry approach to vaccine optimization.
Spassova MK; Bornmann WG; Ragupathi G; Sukenick G; Livingston PO; Danishefsky SJ
J Org Chem; 2005 Apr; 70(9):3383-95. PubMed ID: 15844973
[TBL] [Abstract][Full Text] [Related]
14. A highly efficient synthetic strategy for polymeric support synthesis of Le(x), Le(y), and H-type 2 oligosaccharides.
Zhu T; Boons GJ
Chemistry; 2001 Jun; 7(11):2382-9. PubMed ID: 11446640
[TBL] [Abstract][Full Text] [Related]
15. Immune activation with peptide assemblies carrying Lewis y tumor-associated carbohydrate antigen.
Yamazaki Y; Watabe N; Obata H; Hara E; Ohmae M; Kimura S
J Pept Sci; 2017 Feb; 23(2):189-197. PubMed ID: 27723168
[TBL] [Abstract][Full Text] [Related]
16. Glycomapping the fine specificity of monoclonal and polyclonal Lewis antibodies with type-specific Lewis kodecytes and function-spacer-lipid constructs printed on paper.
Williams E; Korchagina E; Frame T; Ryzhov I; Bovin N; Henry S
Transfusion; 2016 Feb; 56(2):325-33. PubMed ID: 26589374
[TBL] [Abstract][Full Text] [Related]
17. Making Weak Antigens Strong: Cross-Linking Peptides to KLH with Maleimide.
Greenfield EA; DeCaprio J; Brahmandam M
Cold Spring Harb Protoc; 2018 Oct; 2018(10):. PubMed ID: 30275080
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of synthetic conjugates of Lewis(y) oligosaccharide with proteins in mice: towards the design of anticancer vaccines.
Kudryashov V; Kim HM; Ragupathi G; Danishefsky SJ; Livingston PO; Lloyd KO
Cancer Immunol Immunother; 1998 Feb; 45(6):281-6. PubMed ID: 9490197
[TBL] [Abstract][Full Text] [Related]
19. Unusual N-type glycosylation of salivary prolactin-inducible protein (PIP): multiple Lewis
Wiegandt A; Behnken HN; Meyer B
Glycoconj J; 2018 Jun; 35(3):323-332. PubMed ID: 29858715
[TBL] [Abstract][Full Text] [Related]
20. The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serum.
Westwood JA; Murray WK; Trivett M; Haynes NM; Solomon B; Mileshkin L; Ball D; Michael M; Burman A; Mayura-Guru P; Trapani JA; Peinert S; Hönemann D; Miles Prince H; Scott AM; Smyth MJ; Darcy PK; Kershaw MH
J Immunother; 2009 Apr; 32(3):292-301. PubMed ID: 19242371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
